ProfileGDS5822 / ILMN_2549039
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 81% 79% 76% 80% 78% 87% 81% 81% 78% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1157.981
GSM1276600PDAC Late Ablation Control 2128.779
GSM1276601PDAC Late Ablation Control 3135.476
GSM1276602PDAC Late Ablation 1144.380
GSM1276603PDAC Late Ablation 2128.978
GSM1276604PDAC Late Ablation 3352.887
GSM1303940PDAC Late Ablation_anti-CTLA4 1154.281
GSM1303941PDAC Late Ablation_anti-CTLA4 2213.481
GSM1303942PDAC Late Ablation_anti-CTLA4 3155.178